Transcode Therapeutics RNAZ SEC Filings

NASDAQ RNAZ
$1.40 +0.05 (+3.70%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Transcode Therapeutics, Inc. (RNAZ) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001104659-26-119658Oct 28, 2026 8:35 PM
28-KCurrent Report0001104659-26-112826Oct 1, 2026 12:05 AM
38-KCurrent Report0001104659-26-111170Sep 28, 2026 12:16 PM
43Insider Transaction0001104659-26-109371Sep 21, 2026 9:42 PM
54Insider Transaction0001104659-26-107120Sep 11, 2026 9:10 PM
68-KCurrent Report0001104659-26-107115Sep 11, 2026 9:00 PM
710-QQuarterly & Annual Report0001829635-26-000003Aug 14, 2026 9:05 PM
84Insider Transaction0001104659-26-091078Aug 5, 2026 8:05 PM
93Insider Transaction0001104659-26-091074Aug 5, 2026 8:05 PM
10SCHEDULE 13DBeneficial Ownership Report0001104659-26-089819Aug 3, 2026 8:38 PM
118-KCurrent Report0001104659-26-089805Aug 3, 2026 8:15 PM
12SCHEDULE 13GBeneficial Ownership Report0001493152-26-035076Jul 28, 2026 11:51 PM
13SCHEDULE 13GBeneficial Ownership Report0001493152-26-035075Jul 28, 2026 11:50 PM
14SCHEDULE 13GBeneficial Ownership Report0001493152-26-035074Jul 28, 2026 11:48 PM
15SCHEDULE 13DBeneficial Ownership Report0001104659-26-087098Jul 27, 2026 8:15 PM
16SCHEDULE 13DBeneficial Ownership Report0001104659-26-086266Jul 23, 2026 8:15 PM
17424B3Prospectus0001104659-26-085107Jul 20, 2026 9:06 PM
18424B3Prospectus0001104659-26-085105Jul 20, 2026 9:04 PM
198-KCurrent Report0001104659-26-085073Jul 20, 2026 8:15 PM
20SCHEDULE 13DBeneficial Ownership Report0001104659-26-084636Jul 17, 2026 8:15 PM
21DEFA14AOthers0001104659-26-084628Jul 17, 2026 8:08 PM
228-KCurrent Report0001104659-26-084617Jul 17, 2026 8:05 PM
238-KCurrent Report0001104659-26-080311Jul 2, 2026 8:05 PM
248-KCurrent Report0001104659-26-075440Jun 18, 2026 12:00 PM
258-KCurrent Report0001104659-26-069810Jun 3, 2026 12:08 PM
26ARSOthers0001104659-26-069488Jun 2, 2026 8:18 PM
27DEF 14AOthers0001104659-26-069458Jun 2, 2026 8:05 PM
288-KCurrent Report0001104659-26-068647Jun 1, 2026 12:59 PM
29DEFA14AOthers0001104659-26-065966May 26, 2026 10:46 AM
308-KCurrent Report0001104659-26-065959May 26, 2026 10:43 AM
318-KCurrent Report0001104659-26-065728May 22, 2026 8:15 PM
32EFFECTOthers9999999995-26-001704May 19, 2026 4:15 AM
33EFFECTOthers9999999995-26-001703May 19, 2026 4:15 AM
34CORRESPOthers0001104659-26-062704May 15, 2026 8:41 PM
35CORRESPOthers0001104659-26-062701May 15, 2026 8:41 PM
3610-QQuarterly & Annual Report0001104659-26-062535May 15, 2026 8:10 PM
37PRE 14AOthers0001104659-26-058043May 8, 2026 9:20 PM
38UPLOADOthers0000000000-26-004640May 6, 2026 6:30 PM
39UPLOADOthers0000000000-26-004639May 6, 2026 6:30 PM
40S-1Prospectus0001104659-26-053289May 1, 2026 12:58 AM
41S-3Prospectus0001104659-26-053187Apr 30, 2026 9:24 PM
4210-KQuarterly & Annual Report0001104659-26-052941Apr 30, 2026 8:15 PM
43SCHEDULE 13GBeneficial Ownership Report0001104659-26-045551Apr 20, 2026 8:56 PM
4410-KQuarterly & Annual Report0001104659-26-043810Apr 15, 2026 8:17 PM
45DEFA14AOthers0001104659-26-040173Apr 7, 2026 12:37 PM
468-KCurrent Report0001104659-26-040171Apr 7, 2026 12:35 PM
47NT 10-KQuarterly & Annual Report0001104659-26-037743Mar 31, 2026 8:14 PM
48DEFA14AOthers0001104659-26-022837Mar 3, 2026 9:06 PM
498-KCurrent Report0001104659-26-022830Mar 3, 2026 9:05 PM
508-KCurrent Report0001104659-26-018362Feb 23, 2026 1:10 PM
...

Transcode Therapeutics, Inc. SEC Filings API

Pull Transcode Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=RNAZ&formtype=10-K,10-Q&api_key=YOUR_API_KEY